J2840 Injection, sebelipase alfa, 1 mg

Short descriptor: Inj sebelipase alfa 1 mg

✓ Active HCPCS Level II 2026
Open J2840 in the app →

Look up J2840 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J2840 is the HCPCS Level II code for Injection, sebelipase alfa, 1 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2017-01-01
2026 Maintenance
No change this year

Drug Details

Drug / Substance
sebelipase alfa
Dose / Unit
1 mg
Route
Injection

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J2840 with the canonical source and edition:

J2840 — Injection, sebelipase alfa, 1 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J2840

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J2840

Related Codes in Section J

← J2820 Sargramostim injection J2850 → Inj secretin synthetic human
J2805 Sincalide injection J2806 Inj sincalide, maia, 5 mcg J2810 Inj theophylline per 40 mg J2820 Sargramostim injection J2850 Inj secretin synthetic human J2860 Injection, siltuximab J2865 Inj sulfameth/trim 5 mg/1 mg J2910 Aurothioglucose injeciton J2916 Na ferric gluconate complex J2919 Inj, methylpred sod succ 5mg
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial